Drug safety: COVID-19 complicates already challenged FDA foreign inspection program, testimony before the Committee on Finance, U.S. Senate, statement of Mary Denigan-Macauley
Type
Label
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program, testimony before the Committee on Finance, U.S. Senate, statement of Mary Denigan-Macauley
Language
eng
Bibliography note
Includes bibliographical references
resource.governmentPublication
federal national government publication
Illustrations
mapsillustrations
Index
no index present
Literary Form
non fiction
Main title
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program
Medium
electronic resource
Nature of contents
bibliographydictionaries
Oclc number
1156966114
Responsibility statement
statement of Mary Denigan-Macauley
Series statement
Testimony, GAO-20-626-T
Sub title
testimony before the Committee on Finance, U.S. Senate
Subject
- Pharmaceutical industry + Quality control + Evaluation
- Drugs + Safety regulations -- United States -- Evaluation
- COVID-19 (Disease) + Treatment -- United States
- Drugs + Inspection -- United States
- Drug reimportation -- United States -- Evaluation
- Drugs -- United States -- Safety measures -- Evaluation
- Imports -- United States -- Safety measures -- Evaluation
Content
Is Part Of
resource.sponsoringbody
Mapped to
Incoming Resources
- Has instance1
Outgoing Resources
- Contributor2
- Creator1
- Subject7
- Pharmaceutical industry + Quality control + Evaluation
- Drugs + Safety regulations -- United States -- Evaluation
- COVID-19 (Disease) + Treatment -- United States
- Drugs + Inspection -- United States
- Drug reimportation -- United States -- Evaluation
- Drugs -- United States -- Safety measures -- Evaluation
- Imports -- United States -- Safety measures -- Evaluation
- Content1
- Author2
- Is Part Of1
- resource.sponsoringbody1
- Mapped to1